Sold as Lipitor, Atorvaliq. Every FDA application for this active ingredient: 2 branded and 33 generic.
As of Nov 16, 2026, FDA lists 35 applications for Atorvastatin Calcium (sold as Lipitor, Atorvaliq), first approved Dec 17, 1996, with 10 new uses approved and 1 published complete response letter.
| Atorvastatin Calcium | Part D | $818M | +8% | 18,496,074 |
| Lipitor | Part D | $24.9M | -7% | 5,948 |
| Atorvaliq | Part D | $1.6M | +71% | 1,104 |
| Dec 17, 1996 | LipitorNDA 20702 · New molecular entity | Upjohn | 55 | Marketed |
| Nov 30, 2011 | Atorvastatin CalciumANDA 76477 | Sun Pharm Inds Ltd | 14 | Discontinued |
| May 29, 2012 | Atorvastatin CalciumANDA 77575 | Chartwell Rx | 11 | Marketed |
| May 29, 2012 | Atorvastatin CalciumANDA 78773 | Teva Pharms | 0 | Discontinued |
| May 29, 2012 | Atorvastatin CalciumANDA 91226 | Mylan Pharms Inc | 11 | Marketed |
| May 29, 2012 | Atorvastatin CalciumANDA 90548 | Apotex Inc | 11 | Marketed |
| Jul 17, 2012 | Atorvastatin CalciumANDA 202357 | Dr Reddys Labs Ltd | 13 | Marketed |
| Jul 17, 2012 | Atorvastatin CalciumANDA 91650 | Dr Reddys Labs Ltd | 12 | Marketed |
| Apr 5, 2013 | Atorvastatin CalciumANDA 91624 | Lannett Co Inc | 2 | Marketed |
| May 19, 2016 | Atorvastatin CalciumANDA 205519 | Sciegen Pharms | 12 | Marketed |
| Jan 9, 2017 | Atorvastatin CalciumANDA 204846 | Invagen Pharms | 4 | Discontinued |
| Mar 27, 2017 | Atorvastatin CalciumANDA 205300 | Teva Pharms USA | 7 | Marketed |
| Mar 30, 2018 | Atorvastatin CalciumANDA 207687 | Accord Hlthcare | 6 | Marketed |
| Jun 18, 2018 | Atorvastatin CalciumANDA 209912 | Graviti Pharms | 7 | Marketed |
| Nov 20, 2018 | Atorvastatin CalciumANDA 206536 | Zydus Pharms | 7 | Marketed |
| Dec 21, 2018 | Atorvastatin CalciumANDA 209288 | Alkem Labs Ltd | 7 | Marketed |
| Feb 8, 2019 | Atorvastatin CalciumANDA 211933 | Msn | 5 | Marketed |
| Mar 6, 2019 | Atorvastatin CalciumANDA 204991 | Lupin | 5 | Discontinued |
| Nov 7, 2019 | Atorvastatin CalciumANDA 205945 | Micro Labs Ltd India | 5 | Discontinued |
| Jun 23, 2020 | Atorvastatin CalciumANDA 208478 | Perrigo R And D | 3 | Discontinued |
| Aug 19, 2020 | Atorvastatin CalciumANDA 213853 | Umedica | 2 | Marketed |
| Jul 14, 2021 | Atorvastatin CalciumANDA 214659 | Dr Reddys | 3 | Marketed |
| Sep 2, 2021 | Atorvastatin CalciumANDA 214969 | Apotex | 0 | Marketed |
| Nov 3, 2022 | Atorvastatin CalciumANDA 216848 | Lepu Pharm | 0 | Discontinued |
| Nov 23, 2022 | Atorvastatin CalciumANDA 216436 | Biocon Pharma | 2 | Marketed |
| Feb 1, 2023 | AtorvaliqNDA 213260 · New dosage form | Cmp Dev LLC | 1 | Marketed |
| Sep 12, 2023 | Atorvastatin CalciumANDA 214344 | Hetero Labs Ltd V | 1 | Marketed |
| Oct 16, 2023 | Atorvastatin CalciumANDA 212103 | Cadila Pharms Ltd | 1 | Discontinued |
| Dec 21, 2023 | Atorvastatin CalciumANDA 217634 | Strides Pharma | 1 | Discontinued |
| Jan 5, 2024 | Atorvastatin CalciumANDA 217081 | Mankind Pharma | 1 | Marketed |
| Jan 22, 2024 | Atorvastatin CalciumANDA 214513 | Laurus | 0 | Marketed |
| Jan 25, 2024 | Atorvastatin CalciumANDA 211886 | Shandong Xinhua | 0 | Marketed |
| Feb 13, 2024 | Atorvastatin CalciumANDA 217118 | Aurobindo Pharma Ltd | 1 | Marketed |
| Jun 3, 2024 | Atorvastatin CalciumANDA 208480 | Macleods Pharms | 0 | Marketed |
| Nov 13, 2025 | Atorvastatin CalciumANDA 220276 | Teva Pharms Inc | 0 | Marketed |
| Letter | Product | Now |
|---|---|---|
| Oct 16, 2020 | Atorvastatin calciumProduct Quality, Facility Inspections, Clinical Pharmacology | Approved |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA